,66 While no direct evidence regarding BICC1 and CRC has been reported, BICC1 has been found to drive pancreatic cancer progression via inducing VEGF-independent angiogenesis and might serve as a promising anti-angiogenic therapeutic target.66 Here, VEGFA is linked to familial pancreatic carcinoma.